Erratum. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Staged Resection of Difficult-to-Treat Intracranial Meningiomas: A Systematic Review of the Indications, Surgical Approaches, and Postoperative Outcomes.Journal of neurological surgery. Part B, Skull base · 2024
   Article
2. The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy.Neurosurgical review · 2021
   Article
3. A Grade I Intracranial Meningioma with Metastasis to Multiple Vertebral Bodies: A Case Report and Literature Review.Cureus · 2020
   Article
4. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.Journal of neuro-oncology · 2020
   Article
5. An overview of meningiomas.Future oncology (London, England) · 2018
   Review

Corrections and comments

• Erratum for
  Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.2018

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.